41-50 of 59 results

What's in a (biosimilar) name?
Insight 08 Sep 2016

Because biosimilars and their reference biologic medicine are not identical whether compared to each other or even between biosimilars it is important to know which product has been used ...

Dixon Hospitality says cheers to Beer DeLuxe
News 22 Aug 2016

Allens has advised Dixon Hospitality on its acquisition of the Beer DeLuxe venues in NSW and Victoria. Dixon has acquired six venues including those in the entertainment precincts of King Street ...

Costs before Caution - Australia's unique approach to the interchangeability of biosimilars
Insight 17 Aug 2016

Recent developments in Australia suggest that there has been a deliberate prioritisation of the cost benefits of facilitating biosimilar interchangeability over the safety and efficacy risks that can arise when biosimilars are used interchangeably ...

Discussion Paper: Biologic medicines and biosimilars in the Australian landscape - The challenges and the opportunities
Insight 01 Aug 2016

Allens is engaging with stakeholders on the challenges and opportunities presented by biosimilars As part of this engagement we highlight a number of key issues for discussion and comment ...

Protecting innovation without patents - data exclusivity and market exclusivity
Insight 19 Jul 2016

Developments in patent law and the consequential limitations on patentability for biologic medicines mean that data exclusivity and market exclusivity can be the primary protection afforded to originator biologic medicines This is most stark in the US where patent protection for biologic medicines ...

Special Report: Understanding the opportunities and navigating the legal frameworks of distributed ledger technology and blockchain
Insight 17 Jun 2016

Authored by a multidisciplinary team from Allens Blockchain Reaction is designed to assist business stakeholders decision makers and in-house counsel across a variety of sectors to understand the technology and how it is being used as well as navigate the regulatory and legal opportunities and ...

Predictive coding: the future of electronic document production?
Insight 25 Feb 2016

A recent decision of the English High Court may pave the way for the use of predictive coding in large scale discovery and regulatory investigations in Australia Partners Nick Rudge and Duncan Travis Managing Associate Kate Austin and Associate Emily Giblin look at the benefits and risks of the new ...

Patent examination guidelines in the wake of Myriad
Insight 18 Dec 2015

Following public consultation on proposed examination guidelines issued on 16 October 2015 the Commissioner of Patents has established a revised examination practice taking into account the High Courts decision in emDArcy v Myriad Genetics Incem Dr Trevor Davies Partner at Allens Patent amp Trade ...

Allens advises Archer Capital on sale of Healthe Care
News 08 Dec 2015

Allens has advised Archer Capital on its proposed divestment of private hospital business Healthe Care to China's Luye Medical Group. Healthe Care is Australia's third largest private hospital ...

Government rejigs electronic health records system with opt-out approach
Insight 21 Oct 2015

The Federal Governments electronic health records system may have a new lease on life following the introduction of a new Bill that attempts to improve the systems effectiveness with key changes such as the transition to an opt-out approach Partner Ian McGill Senior Associate Phil OSullivan and ...

Refine